BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31258751)

  • 1. Predictors of the survival of patients with chondrosarcoma of bone and metastatic disease at diagnosis.
    Wang Z; Chen G; Chen X; Huang X; Liu M; Pan W; Yan X; Lin N; Ye Z
    J Cancer; 2019; 10(11):2457-2463. PubMed ID: 31258751
    [No Abstract]   [Full Text] [Related]  

  • 2. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
    Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
    Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.
    Schneiderman BA; Kliethermes SA; Nystrom LM
    Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for survival among patients with primary bone sarcomas of small bones.
    Wang Z; Li S; Li Y; Lin N; Huang X; Liu M; Pan W; Yan X; Sun L; Li H; Li B; Qu H; Wu Y; Lin P; Ye Z
    Cancer Manag Res; 2018; 10():1191-1199. PubMed ID: 29795990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery plus chemotherapy improves survival of patients with extremity soft tissue leiomyosarcoma and metastasis at presentation.
    Qian SJ; Wu JQ; Wang Z; Zhang B
    J Cancer; 2019; 10(10):2169-2175. PubMed ID: 31258720
    [No Abstract]   [Full Text] [Related]  

  • 6. Surgical Resection of Primary Ewing's Sarcoma of Bone Improves Overall Survival in Patients Presenting with Metastasis.
    Ren Y; Zhang Z; Shang L; You X
    Med Sci Monit; 2019 Feb; 25():1254-1262. PubMed ID: 30770526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival Analysis of Patients with Osseous Malignant Vascular Tumors: Results of the Surveillance, Epidemiology, and End Results (SEER) Database from 1973 to 2015.
    Wang W; Hong J; Meng J; Wu H; Shi M; Yan S; Huang Y
    Med Sci Monit; 2019 Jul; 25():5525-5535. PubMed ID: 31344019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and prognostic analysis of patients with chest wall chondrosarcoma.
    Gao H; Zhou Y; Wang Z; Zhao R; Qian S
    Medicine (Baltimore); 2019 Sep; 98(36):e17025. PubMed ID: 31490388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Factors and Treatment Options for Patients with High-Grade Chondrosarcoma.
    Gao Z; Lu T; Song H; Gao Z; Ren F; Ouyang P; Wang Y; Zhu J; Zhou S; He X
    Med Sci Monit; 2019 Nov; 25():8952-8967. PubMed ID: 31765367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of the Survival of Primary and Secondary Older Osteosarcoma Patients.
    Wang Z; Wu B; Zhou Y; Huang X; Pan W; Liu M; Yan X; Lin N; Ye Z
    J Cancer; 2019; 10(19):4614-4622. PubMed ID: 31528225
    [No Abstract]   [Full Text] [Related]  

  • 11. Chondrosarcoma of the Osseous Spine: An Analysis of Epidemiology, Patient Outcomes, and Prognostic Factors Using the SEER Registry From 1973 to 2012.
    Arshi A; Sharim J; Park DY; Park HY; Bernthal NM; Yazdanshenas H; Shamie AN
    Spine (Phila Pa 1976); 2017 May; 42(9):644-652. PubMed ID: 28441682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinicopathological characteristics and prognosis of young patients with chondrosarcoma of bone.
    Xie T; Sun Y; Han X; Zhang J
    Front Surg; 2022; 9():926008. PubMed ID: 36132200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment method and prognostic factors of chondrosarcoma: based on Surveillance, Epidemiology, and End Results (SEER) database.
    Hua KC; Hu YC
    Transl Cancer Res; 2020 Jul; 9(7):4250-4266. PubMed ID: 35117792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional Survival Analysis for Spinal Chondrosarcoma Patients After Surgical Resection.
    Song K; Lin K; Guan H; Li F
    Spine (Phila Pa 1976); 2020 Aug; 45(16):1110-1117. PubMed ID: 32205690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival predictors of metastatic angiosarcomas: a surveillance, epidemiology, and end results program population-based retrospective study.
    Ren S; Wang Y; Wang Z; Shao J; Ye Z
    BMC Cancer; 2020 Aug; 20(1):778. PubMed ID: 32811474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
    Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
    Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival analysis and treatment strategies for limb liposarcoma patients with metastasis at presentation.
    Wang S; Zhou Y; Wang H; Ling J
    Medicine (Baltimore); 2021 Apr; 100(13):e25296. PubMed ID: 33787618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of patients with extremity myxoid liposarcomas after surgery.
    Wu J; Qian S; Jin L
    J Orthop Surg Res; 2019 Mar; 14(1):90. PubMed ID: 30922351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for postoperative survival among patients with rhabdomyosarcoma of the limbs.
    Ren S; Wang Z; Huang X; Sun L; Shao J; Ye Z
    Cancer Manag Res; 2018; 10():4181-4189. PubMed ID: 30323674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.